Olivia
Online
Rafarma Pharmaceuticals Inc
@RafarmaPharma
Rafarma is a diversified multi-product Pharmaceutical Co. which develops and produces biotech & nuclear medicines with our partner companies since 1930 $RAFA
Wyoming
Joined September 2020
61 Following
238 Followers
270 Posts
Pinned Tweet
$RAFA 2022 Year End Financial Report
https://t.co/qtAYwFRQmW
2022 Sales Revenues = $64.3 Million
Net Income = $5 Million
EPS = $0.056c
CASH on Hand = $18 Million
Total Assets = $98.3 Million
Shares Outstanding = Unchanged @ 87.7 Million
$RAFA Call with Management
12 Noon EST Dec 18th
Join Zoom Meeting https://t.co/XAn8GQx3Im
Meeting ID: 862 9482 9794
Passcode: 564976
$RAFA News
Rafarma has entered into a preliminary agreement with Kelun Lifesciences (Pvt) Ltd, a Pharmaceutical Company based in Sri Lanka
https://t.co/PUJWI0vgpA
$RAFA - Rafarma Pharmaceuticals Signed a Preliminary Agreement for Radiopharmaceutical Production Center
https://t.co/AnfNPhwAtM
Who to follow
A2Z Cust2Mate Corp NASDAQ $AZ
@CorpA2z
Cust2Mate is transforming brick-and-mortar retail with innovative smart shopping cart solutions that digitize the in-store shopping experience.
ARS Pharmaceuticals 
@ars_pharma
We are revolutionizing the treatment for severe allergic reactions with the development of an easy-to-use, needle-free epinephrine nasal spray.
SOMAÍ
@somaipharma
A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint of distribution cannabinoid-containing medicine
$RAFA - Rapharma and Kelun Lifesciences have entered into a preliminary agreement
https://t.co/9Vo7DELkBx
$RAFA News Release
https://t.co/wiQKz7n8YJ
$RAFA Q2 2023 Combined Financial statements
https://t.co/xn4GZMd2Tp
Revenues $21 million
Assets $80 million
Cash $14 million
Income $2.3 million
Shares outstanding - unchanged
$RAFA Recent Activity ...
Opening enterprise HONG KONG - CHINA
Developing Projects in KAZAKHSTAN
Negotiating with an Investment Fund - CHINA
Meeting with CERES F&D - KOREA
Expansion of production - ISRAEL
Agreement with Istem Medikal - TURKEY
Tashkent Pharma Park - UZBEKISTAN
Updated $RAFA Filing 07/06/23 at OTC Markets
https://t.co/9kBoZEuOHX
The global nuclear medicine market size was estimated at USD $9.1 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.8% from 2023 to 2030
ABOUT LONG SHENG PHARMA
A Subdivision of the Chinese State Pharmaceutical Group https://t.co/yYxH3QeAXm
$RAFA Rafarma plans to open an enterprise in Hong Kong
https://t.co/HKq1nZ0YCG
Our Partner Long Sheng Pharma Ltd, a Hong Kong manufacturing, pharmaceutical equipment, raw materials Co.
Parties plan to set up a joint venture in #HongKong with the registration of a new company.
$RAFA - Rafarma continues to develop projects on isotopes in Kazakhstan. Negotiations with The Institute of Nuclear Physics of the Ministry of Energy of the Republic of #Kazakhstan
https://t.co/HKq1nZ0YCG
Parties continue to discuss cooperation and evaluate production volumes
$RAFA - Rafarma Pharmaceuticals is negotiating with an Investment Fund
https://t.co/HKq1nZ0YCG
Rafarma Pharmaceuticals, Inc. (OTC: RAFA) Chairman of the Board Ilya Shpurov met with the representatives of the investment fund located in Hangzhou City, China.
$RAFA Rafarma Pharmaceuticals meets to discuss partnership with Korean CEO Jae Min Son from CERES F&D Inc. https://t.co/HKq1nZ0YCG
CERES is a Biopharmaceutical Co with cGMP-certified production facilities that produces high quality, effective medicines https://t.co/IPgPEcyxtk
$RAFA 2023 - Q1 Financial Highlights
$87.3 Million in Assets
$10.1 Million in Revenues
$15.1 Million Cash
Shares Outstanding - Unchanged 87.7 Million
Latest News - https://t.co/HKq1nZ1wse
$RAFA Q1 2023
Financial Results
https://t.co/wnGqagLHaV
$RAFA Q1 2023
Financial Results
https://t.co/wnGqagLHaV
$RAFA Rafarma Pharmaceuticals negotiated with the Ministry of Kazakhstan
https://t.co/HKq1nZ0YCG
$RAFA Rafarma will participate in a conference dedicated to modern Neuroscience
https://t.co/HKq1nZ0YCG
Ilya Shpurov Chairman #RAFA is the
Conference organizing committee member
Landmark event for leading Scientific Centers & Universities
200 Universities will participate
$RAFA
Israel has a strong position in the pharmaceutical industry & an excellent reputation in the biomedicine market
Rafarma Pharmaceuticals sees large-scale prospects for its growth in the country & opportunities for the implementation of the projects
https://t.co/uebhO0r0KD
$RAFA Rafarma has Registered NOYA THERAPEUTICS company in Israel
RAFA continues to develop business, expand, strengthen its position in the Israeli market
Israeli Corporations Authority (ICA) registered NOYA THERAPEUTICS LTD co
https://t.co/HKq1nZ0YCG
$RAFA Rafarma has Registered NOYA THERAPEUTICS company in Israel
RAFA continues to develop business, expand, strengthen its position in the Israeli market
Israeli Corporations Authority (ICA) registered NOYA THERAPEUTICS LTD co
https://t.co/HKq1nZ0YCG
Most Popular Users
Elon Musk
@elonmusk
240.7M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.8M followers
Taylor Swift
@taylorswift13
81.7M followers
Lady Gaga
@ladygaga
73.2M followers
Virat Kohli
@imvkohli
70.1M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
62.9M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
60.9M followers
X
@x
60.8M followers